What is the recommended follow-up/surveillance schedule following organ preservation treatment approach for cT1-2N0 rectal cancer?
Taking into account follow up from NEO, OPERA and other organ preservation trials?
Answer from: Medical Oncologist at Community Practice
Patients with stage I rectal cancer treated with organ preservation require close surveillance to rule out tumor regrowth and local recurrence that may be salvaged with radical surgery. The highest risk of recurrence is within 2 years after completion of neoadjuvant therapy and patients should be fo...
Comments
Radiation Oncologist at West Virginia University In our experience, insurers will not cover the rig...
Medical Oncologist at McLeod Regional Medical Center at McLeod Seacoast An answer to this question would require a large a...
Answer from: Radiation Oncologist at Academic Institution
Here's what we know.
Recurrences are often asymptomatic hence, it is unreliable to follow up based on symptoms alone. Besides, by the time recurrence become symptomatic, they are often locally advanced and not amenable for salvage.
MRI (or EUS) is better than CT in evaluating rectal tumors espec...
Comments
Radiation Oncologist at Washington University School of Medicine If you're following a patient with a T1 or T2 rect...
In our experience, insurers will not cover the rig...
An answer to this question would require a large a...